Torrent Pharmaceuticals — Q4 FY2018-19 Earnings Presentation

4 slides from Torrent Pharmaceuticals's earnings presentation, May 20, 2019

Slide 1: Exchange filing cover letter for analyst presentation
m;orrent- w PHRRmR 201h May, 2019 The Dy. General Manager (Listing Dept.) The Manager- Listing Dept., BSE Limited., National Stock Exchange oflndia Ltd., Corporate Relationship Dept., Exchange Plaza, 51h Floor, 1st Floor, New Trading Ring, Plot No. C/1, G. Block, P. J. Towers, Dalal Street, Fort,· B
Slide 2: Q4 FY 2018-19
torrent PHARMA
Slide 3: Consolidated Revenues for Q4 2018-19
Consolidated Revenues for Q4 2018-19 (` Crore) Particulars Q4 1819 Q4 1718 Gr% India 754 693 9% US 372 307 21% Brazil 205 215 -4% Germany 240 234 2% Other 178 132 35% Others (Incl contract Mfg.) 107 127 -16% Total 1,856 1,708 9% 2
Slide 4: Consolidated Revenues for FY 2018-19
Consolidated Revenues for FY 2018-19 (` Crore) Particulars YTD 1819 YTD 1718 Gr% India 3,234 2,351 38% US 1,589 1,100 45% Brazil 689 709 -3% Germany 1,009 860 17% Other 680 522 30% Others (Incl contract Mfg.) 472 408 16% Total 7,673 5,950 29% 3